<DOC>
	<DOCNO>NCT02810509</DOCNO>
	<brief_summary>The current study aim assess quality anticoagulation warfarin real world practice secondary stroke prevention Korean patient Atrial fibrillation ( AF ) explore predictor poor International Normalized Range ( INR ) control .</brief_summary>
	<brief_title>Quality Anticoagulation With Warfarin Patient With Atrial Fibrillation Secondary Stroke Prevention Korea</brief_title>
	<detailed_description>- To assess quality anticoagulation warfarin real world practice Korea secondary stroke prevention patient AF-related Cardioembolic ( CE ) stroke 1 ) initiate warfarin therapy treatment least 7 day warfarin adjustment period ( warfarin-initiated cohort ) , 2 ) initiate maintain warfarin therapy least 90 day 7 day warfarin adjustment period ( long-term warfarin-treated cohort ) . - To explore predictor poor INR control .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Inclusion criterion warfarininitiated cohort 1 . Admission due AFrelated ischemic stroke 2 . Initiation warfarin therapy treatment least 7 day warfarin adjustment period 3 . For TTR calculation , available consecutive INR value ≥3 7 day warfarin adjustment Inclusion criterion longterm warfarintreated cohort 1 . Admission due AFrelated ischemic stroke 2 . Longterm warfarin therapy least 90 day 7 day warfarin adjustment period 3 . For TTR calculation , available consecutive INR value ≥3 7 day warfarin adjustment 4 . TTR evaluable day ≥ 90 day 1 . AF mechanical valve 2 . Enrollment anticoagulation randomize clinical trial 3 . Enrollment study affect target INR range .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Wafarin</keyword>
	<keyword>Cardioembolic ( CE ) stroke</keyword>
	<keyword>ischemic stroke</keyword>
</DOC>